Research on Current Progress in Penile Cancer

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".

Deadline for manuscript submissions: 25 July 2024 | Viewed by 794

Special Issue Editors


E-Mail Website
Guest Editor
Department of Urology, The University of Arizona, 1200 E University Blvd, Tucson, AZ 85721, USA
Interests: urology

E-Mail Website
Guest Editor
Department of Urology, University of Arkansas for Medical Sciences, 4301 W. Markham St., Little Rock, AR 72205, USA
Interests: urology

Special Issue Information

Dear Colleagues,

Penile squamous cell carcinoma (PSCC) is an aggressive cancer associated with significant treatment morbidity and psychosocial stress. Metastatic PSCC has a dismal prognosis and its treatment relies on the utilization of conventional treatments employing a multidisciplinary approach. However, there is a paucity of actionable therapeutic or salvage systemic options. Thus, there is an urgent need to expand knowledge on the genomic and molecular landscape of PSCC, as well as increase the awareness of current trials and research on therapeutic paradigms for PSCC. In addition, the impact of PSCC on the quality of life of survivors and their family needs to be examined further. With this Special Issue, we hope to provide a comprehensive and contemporary review on current management strategies for this rare disease.     

Dr. Juan J. Chipollini
Dr. Ahmet Murat Aydin
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

12 pages, 437 KiB  
Review
Improving Quality of Life and Psychosocial Health for Penile Cancer Survivors: A Narrative Review
by Von Marie Torres Irizarry, Irasema Concepcion Paster, Vanessa Ogbuji, D’Andre Marquez Gomez, Kyle Mccormick and Juan Chipollini
Cancers 2024, 16(7), 1309; https://doi.org/10.3390/cancers16071309 - 28 Mar 2024
Viewed by 494
Abstract
Treatment of penile cancer (PC) focuses on organ preservation, employing various surgical and non-surgical approaches. These interventions may lead to disfigurement, impacting patients’ functional outcomes and psychosocial well-being. We reviewed studies related to penile health and PC up to February 2024, limited to [...] Read more.
Treatment of penile cancer (PC) focuses on organ preservation, employing various surgical and non-surgical approaches. These interventions may lead to disfigurement, impacting patients’ functional outcomes and psychosocial well-being. We reviewed studies related to penile health and PC up to February 2024, limited to studies published in English. Studies employing health-related quality of life (HRQoL) assessments have identified a detrimental association between aggressive treatment and overall health status, physical functioning, and relationships. In contrast, organ-sparing demonstrates improved measures related to HRQoL and sexual function. Assessment through validated questionnaires reveals diverse voiding outcomes, and varying impacts on QoL and sexual activity, emphasizing the necessity for multidisciplinary personalized care. Studies highlight substantial variations in sexual function, with patients reporting adaptations, reduced satisfaction, and concerns about body image and sexual well-being. Furthermore, unmet needs include challenges in patient–clinician communication, obtaining information, and accessing psychosocial support. Patient experiences underscore the importance of timely diagnosis, treatment access, and addressing psychological consequences. Organ-sparing approaches have higher QoL preservation and sexual function. Individualized support, including sexual therapy, support groups, and family counseling, is essential for post-treatment rehabilitation. Timely diagnosis and comprehensive care are paramount in addressing the multifaceted impact of PC on patients and families. Full article
(This article belongs to the Special Issue Research on Current Progress in Penile Cancer)
Show Figures

Figure 1

Back to TopTop